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2- and 20-fold, the amount of human serum required was 
reduced by at least two thirds over the SPOT TM membrane 
technique using the microarray. After subtraction of the po-
tential background, we did not observe non-specific binding 
to the presented peptides on microarray.  Conclusions: The 
novel peptide microarray allows simple and cost-effective 
screening for potential epitopes of large allergenic legume 
seed storage proteins, and it could be adapted for other food 
allergens as well, to study allergenic epitopes at the individ-
ual subject level in large paediatric and adult study groups 
of food allergic subjects.  © 2015 S. Karger AG, Basel 
 Introduction 
 Food allergy, an IgE antibody-mediated and potential-
ly life-threatening  [1] chronic immunological disease, is 
a significant clinical problem in Europe and appears to 
have increased within the past years  [2] . Based on clinical 
food challenge data, peanut and soybean are among the 
most prevalent elicitors of allergic reactions to foods in 
Europe  [3] .
 Epitope mapping of B-cell epitopes, i.e. the immuno-
globulin-binding structures of proteins, is a fundamental 
tool to understand the antigen-antibody interaction of the 
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 Abstract 
 Background: The identification of B-cell epitopes of food al-
lergens can possibly lead to novel diagnostic tools and ther-
apeutic reagents for food allergy. We sought to develop a 
flexible, low-tech, cost-effective and reproducible multipep-
tide microarray for the research environment to enable 
large-scale screening of IgE epitopes of food allergens.  Meth-
ods: Overlapping peptides (15-mer, 4 amino acid offset) 
 covering the primary sequence of either peanut allergen 
Ara h 1 or all 3 subunits of the soybean allergen Gly m 5 were 
simultaneously synthesized in-house on a porous cellulose 
matrix. Identical peptide microarrays created with up to 384 
duplicate peptide-cellulose microspots each were investi-
gated for specificity and sensitivity in IgE immunodetection 
and in direct experimental comparison to the formerly es-
tablished SPOT TM membrane technique.  Results: The in-
house microarray identified with 98% reproducibility the 
same IgE-binding peptides as the SPOT TM membrane tech-
nique. Additional IgE-binding peptides were identified using 
the microarray. While the sensitivity was increased between 
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human immune response. B-cell epitopes can be classified 
into two categories: (i) discontinuous epitopes where two 
or more binding regions are discontinuously located in the 
primary structure and full antibody reactivity depends on 
the intact conformation of the antigen and (ii) continuous 
or linear epitopes, merely consisting of the conformation 
of the primary amino acid sequence  [4] . Considering the 
harsh conditions of food technological processing and 
protein digestion in the human gastrointestinal tract, 
complete native structural integrity may play a minor role 
in immunoglobulin binding to cause clinical reactivity in 
food allergy. Based on observations that short stretches of 
classical food allergens retain at least partial IgE-binding 
capacity, several studies aimed at identifying IgE-binding 
stretches that are involved in the allergic disease by screen-
ing against an array of synthetic overlapping peptides that 
cover the complete primary allergen sequence. Accord-
ingly, diagnostic markers for severe allergic reactions  [5] 
or persistent food allergy may be identified  [6, 7] . In addi-
tion, knowledge of the B-cell epitopes of allergens allows 
designing hypoallergenic immunotherapeutic peptides of 
allergenic molecules  [8, 9] or hypoallergenic variants of al-
lergens for immunotherapy  [10] .
 To date, synthetic peptide arrays for food allergen 
analysis have largely been generated on cellulose mem-
branes with SPOT TM peptide synthesis, which gives the 
opportunity to synthesize a large number of individual 
peptides in parallel  [11–13] . Detailed information about 
the most common IgE-binding epitopes of a food allergen 
can only be obtained by screening a large number of sera 
from allergic patients at the individual subject level. Un-
fortunately, the SPOT TM membrane technique is not par-
ticularly suitable as a screening tool for such analyses, 
mainly because the synthesis and immunodetection of a 
large number of peptides is time consuming and requires 
high quantities of chemicals and especially precious and 
limited patients’ sera. Hence, various different peptide 
microarrays have been developed to reduce the amount 
of serum required. As additional key features for food al-
lergen epitope analysis resolved at the individual subject 
level, such a peptide microarray would need to allow the 
simultaneous screening of identical array replicates of 
even large proteins that consist of several subunits, such 
as the peanut and soybean major storage proteins. A com-
mon design of peptide microarrays for allergen analysis 
has been the separate synthesis of overlapping peptides 
following automated spotting or printing onto modified 
surfaces of arrays slides  [14–20] .
 In the field of food allergen IgE epitope analysis, one 
peptide microarray appeared to be well validated  [20] . It 
was based on commercially synthesized overlapping pep-
tides which were printed onto epoxy-derivatized glass 
slides. The binding of human serum IgE was recorded by 
fluorescence detection using an array reader. In our study, 
we aimed at developing a multipeptide microarray having 
comparable performance characteristics while, for rea-
sons of cost-efficiency and flexibility, setting up an in-
house multipeptide synthesis and a simple and cost-effec-
tive microarray spotting and detection procedure. We 
chose the Celluspot TM array platform that makes use of 
peptides covalently synthesized on a cellulose porous 
membrane which builds a 3-dimensional structure that is 
spotted and attached onto a standard microscope slide 
 [21] . The method has already been applied for determin-
ing antibody specificities to phosphotyrosin  [22] or his-
tone tail posttranslational modifications  [23] . In this 
study, we investigated the potential of the multipeptide 
microarray in comparison to the well-established SPOT TM 
membrane technology  [11, 13] for its handling, sensitiv-
ity and specificity in the identification of human IgE-
binding epitopes of legume seed storage proteins related 
to the allergic disease. Allergen peptide-specific human 
IgE was detected by chemiluminescence on X-ray film, 
and signals were analysed with open source array software 
after digitalization. As an example, overlapping 15-mer 
peptides of either the peanut major allergen Ara h 1  [24] 
or all 3 subunits of the homologous allergenic soybean 
major storage protein β-conglycinin  [25] , namely Gly m 
5.01 (α), Gly m 5.02 (α´) and Gly m 5.03 (β), were analysed 
using both the SPOT TM membrane and our in-house mi-
croarray method. The results demonstrate that this novel, 
simple and cost-effective peptide microarray is suitable 
for the identification of allergenic epitopes at the individ-
ual subject level in large paediatric and adult study groups 
of food allergic subjects.
 Methods 
 Human Sera 
 Inclusion criteria for human subjects were a clinically con-
firmed food allergy to soybean on the basis of a convincing history 
of anaphylaxis to soybean (No. 28 and 8)  [26] or a positive oral 
challenge with soybean (No. 25). All subjects included had a con-
vincing history of peanut allergy. Specific IgE (sIgE) to soy and 
peanut extract and to recombinant peanut allergen Ara h 1 as well 
as to natural soybean allergen Gly m 5 was quantified using the 
ImmunoCAP TM system (Thermo Fisher Scientific, Uppsala, 
 Sweden). As a negative control, a serum pool consisting of equal 
volumes of sera from 6 non-allergic (NA) human subjects from an 
in-house serum collection was applied. Sera with sIgE levels >0.35 
kU A /l are considered positive. Further details are given in  table 1 .
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 Synthesis of Overlapping Peptides on Cellulose SPOT TM 
Membranes 
 Arrays of overlapping peptides (15 amino acids, offset of 4 ami-
no acids) of the primary sequence of the mature forms of peanut 
allergen Ara h 1 and the 3 subunits of the homologous soybean al-
lergen Gly m 5, namely Gly m 5.01 (α subunit), 5.02 (α’ subunit) 
and 5.03 (β subunit), were synthesized according to the principles 
of Merrifield  [27] . Using the SPOT TM technique  [11, 13] , the simul-
taneously synthesized peptides were covalently bound to an ami-
no-PEG 500 derivative cellulose membrane (Intavis AG, Cologne, 
Germany) using an automated multiple peptide synthesizer with 
up to 600 peptide spots per membrane according to the manufac-
turer’s instructions (MultiPep, Intavis AG). After peptide synthe-
sis, the side chain protection groups of the amino acids were de-
protected with a mixture of dichloromethane/trifluoroacetic acid/
triisopropylsilane/water in a ratio of 1: 1:0.06: 0.04. The N terminus 
was blocked by acetylation. According to the manufacturer of the 
multiple peptide synthesizer, the purity of the peptides should be 
better than 70%. Membranes with synthesized peptides were 
stored under dry conditions at 4   °   C until use. Details about the 
proteins and the derived synthetic overlapping peptides are given 
in  table 2 . Physical details about the SPOT TM membranes are listed 
in  table 3 .  Figure 1 displays 2 SPOT TM membranes that present 145 
Ara h 1-related peptides which were immunostained by the NA 
serum pool and the serum No. 28 of a peanut- and soybean-allergic 
donor, respectively.
 Synthesis and Preparation of Overlapping Celluspot TM Peptides 
for Microarrays 
 Arrays of overlapping synthetic peptides (15 amino acids, offset 
of 4 amino acids) of Ara h 1, Gly m 5.01, 5.02 and 5.03 were syn-
thesized as described above except for an Fmoc-β-alanine etheri-
fied cellulose membrane (Intavis AG) as the solid phase. After pep-
tide synthesis, all peptide spots were cut from the membrane using 
a puncher (Intavis). Each membrane disc carrying an individual 
peptide was dissolved over night with 250 μl of a mixture of tri-
fluoroacetic acid/trifluoromethanesulphonic acid/triisopropylsi-
lane/water (89.5: 4:2.5: 4). Thereafter, 750 μl of –20   °   C cold tert-
butylmethylether were added to each peptide, and the peptides 
were stored at –70  °  C for 1 h. The precipitated peptides were cen-
trifuged at 2,000  g for 10 min at 0   °   C. The ether supernatant was 
removed, and the peptide pellet was washed twice each with 500 μl 
of –20  °  C cold tert-butylmethylether and centrifuged at 2,000  g for 
10 min at 0  °  C. After ether removal, the peptide pellet was dissolved 
in 300 μl dimethylsulphoxide (DMSO). An aliquot of 50 μl of each 
dissolved peptide was pipetted into dedicated wells of a 384-well 
ELISA plate.
 Generation of Peptide Microarrays 
 Using a slide-spotting robot (Intavis AG), the DMSO stocks of 
the overlapping 15-mer peptides of peanut Ara h 1 and the 3 sub-
units of soybean Gly m 5 were spotted onto microscope slides (26 × 
76 mm) coated with white adhesive foil (Intavis AG) in 2 identical 
 Table 1.  Characteristics of human serum samples from peanut- and soybean-allergic patients and NA control
Patient
No.
Food allergy Specific IgE according to Im munoCAPTM analysis, kUA/l
Ara h 1 peanut Gly m 5 soybean
28 Peanut, soybean >100 >100 23.10 52.51
8 Peanut, soybean <0.35 2.301 n.d. 15.91
25 Peanut, soybean >100 >100 13.30 30.0
NA NA n.d. n.d. n.d. n.d.
 NA denotes the sera pool with 6 NA subjects from the Paul-Ehrlich-Institut (PEI), Division of Allergology, 
in-house serum collection (PEI-19, -208, -230, -231, -233, -245). n.d. = Not determined.
1 Ballmer-Weber et al. [26], 2007. 
 Table 2.  Investigated allergenic 7S seed storage proteins from peanut and soybean: protein identity and number 
of array peptides (15 amino acids length, 4 amino acid offset) 
Allergen Protein UniProt entry Sequence coverage (aa) Array peptides, n
Ara h 1 Peanut vicilin P43237 26–614 145
Gly m 5.01 Soybean β-conglycinin, α subunit O22120 1–543 133
Gly m 5.02 Soybean β-conglycinin, α’ subunit Q9FZP9 1–559 137
Gly m 5.03 Soybean β-conglycinin, β subunit P25974 24–439 102
 Allergens are defined according to the International Union of Immunological Societies Allergen Nomencla-
ture Sub-Committee (www.allergen.org). The investigated amino acid sequence covers the mature protein pri-
mary sequence without signal peptide (according to Maruyama et al. [42], 1998). aa = Amino acid.
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segments of 145 and 372 peptide spots each, respectively. On Gly 
m 5 microarrays, peptides related to the subunits Gly m 5.03, Gly 
m 5.01 and Gly m 5.02 were spotted on positions 3–104, 106–238 
and 241–377. Additional 5 spots of solid-phase cellulose without 
peptide were dissolved in DMSO and spotted as a control for back-
ground measurement. The negative spots were located at the spot 
positions 146–150 and 378–382 for Ara h 1 and Gly m 5 slides, 
respectively ( fig. 2 , fig. 5, right). Each 0.04 μl/spot were spotted ac-
cording to the manufacturer’s instructions (Intavis AG) at a 1.2-
mm spot-to-spot distance. The spotted microscope slides were 
dried at 75  °  C for 1 h and subsequently stored under dry conditions 
at 4  °  C until use. Physical details about the peptide microarray are 
given in  table 3 .
 IgE Epitope Mapping on SPOT TM Membranes 
 Prior to blocking, the entire cellulose membrane (150 × 
100 mm) was cut into separate segments (50 × 50 mm) with each 
segment representing 1 protein, i.e. Ara h 1 or 1 subunit each of 
Gly m 5 ( fig. 1 , fig. 5, left). The cellulose membrane segments 
were blocked over night with Spots Blocking Buffer 10X (Sigma-
Genosys, The Woodlands, Tex., USA) diluted 1: 10 in Tris-buff-
ered saline (TBS; 50 m M Tris, pH 7.4) containing 0.05% Tween 
20 and 5% sucrose. Thereafter, each protein segment was incu-
bated over night with 50 μl human serum diluted in 4 ml blocking 
buffer. For a sIgE detection, the membrane was successively in-
cubated for 1 h each with 4 ml anti-human IgE from goat (KPL, 
1–20
21–40
41–60
61–80
81–100
101–120
121–140
141–160
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1–20
21–40
41–60
61–80
81–100
101–120
121–140
141–160
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
a
b
 Fig. 1. SPOT TM membranes for the IgE epi-
tope mapping of peanut allergen Ara h 1. 
IgE immunodetection of 145 overlapping 
synthetic peptides using a serum pool of 6 
NA subjects ( a ) and serum of peanut- and 
soybean-allergic subject No. 28 ( b ). Con-
secutive numbers indicate the position of 
individual peptides. 
 Table 3.  Characteristics of SPOTTM membrane and CelluspotTM-
based microarrays in this study
Parameter SPOTTM 
membrane (A)
Microarray 
(B)
Ratio 
B/A
Max. capacity of peptide spots 1×600 2×384 1.28
Max. size, mm × mm 100×150 22×60 0.09
Spot diameter, mm 2.5 0.8 0.32
Spot density, n/cm2 4 81 20.25
Peptide density, pmol/mm2 1,000 10 0.01
Synthesis time, weeks/50 
membranes or slides 25 3 0.12
Required amount of serum, 
μl/n peptides 50/145 45/384 0.34
Sensitivity for Ara h 1 17/145 34/145 2.001
Sensitivity for Gly m 5 8/372 162/372 20.252
Specificity for Ara h 1 145/145 145/145 1.00
Specificity for Gly m 5 371/372 372/372 1.00
 Parameters are determined according to the instrument configuration 
available and application done. Sensitivity is defined as <positive/total 
spots>. Specificity is defined as <negative/total spots>.
1 34/145 are double positive in all 5 microarray replicates; 44/145 are ≥1/2 
positives in all 5 replicates; sensitivity is 2.00–2.59 times higher than that of 
SPOTSTM.
2 All positives of the 2 sera were counted.
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Gaithersburg, Md., USA, via Medac, Hamburg, Germany) dilut-
ed 1: 5,000 in blocking buffer and with 4 ml horseradish peroxi-
dase-conjugated anti-goat IgG from rabbit (Dianova, Hamburg 
Germany) diluted 1: 50,000 in blocking buffer. Finally, the mem-
brane segments were incubated for 1 min with LumiGlo  Reserve TM 
chemiluminescence substrate (KPL), and chemiluminescence 
was recorded on X-ray film by a maximum of 60-min exposure 
 (Amersham Hyperfilm TM ECL, GE Healthcare, Little Chalfont, 
UK). Between all incubation steps, membrane segments were 
washed 4 times with TBS and 0.05% Tween 20. Positive spots of 
membranes incubated with human serum from allergic donors 
were identified visually in comparison to the control of NA se-
rum ( fig. 1 , fig. 5, left).
 IgE Epitope Mapping on Peptide Microarrays 
 Microscope slides with bound peptides were blocked for 2 h and 
washed as described above. Washed slides were air dried for 1 h. To 
the microscope slides with Gly m 5 peptides, 45 μl of undiluted hu-
 Fig. 2. Peptide microarray for the IgE epitope mapping of peanut 
allergen Ara h 1. IgE immunodetection of 145 overlapping syn-
thetic peptides using a serum pool of 6 NA subjects ( a ) and serum 
of peanut- and soybean-allergic subject No. 28 on 5 replicate (B1–
B5) slides ( b–f ) from 1 peptide synthesis batch. Each slide presents 
duplicate peptide segments (left/right). Consecutive numbers in-
dicate the position of individual peptides. The peptides No. 27 and 
91 are marked in red and blue colour, respectively (colours refer to 
the online version only). 
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man serum were applied to a glass cover slip with spacer (22 × 
60 mm) (MicroArray Lifter Slips, Nunc, Germany) on top of the 
spotted peptide area. The serum, which was injected at the right seg-
ment and underneath the cover slip, was drawn from right to left by 
capillary action. To the microscope slides with Ara h 1 peptides, 
29 μl undiluted human serum were applied to a smaller cover slip 
(22 × 40 mm) (MicroArray Lifter Slips, Nunc, Germany) as de-
scribed above. The microscope slides were incubated in a wet cham-
ber at room temperature overnight. After removing the cover slips, 
the microscope slides were incubated for 1 h with 4 ml anti-human 
IgE from goat (KPL) diluted 1: 5,000 in blocking buffer following 1 h 
of incubation with 4 ml horseradish peroxidase-conjugated anti-
goat IgG from rabbit (Dianova) diluted 1: 50,000 in blocking buffer. 
Between all incubation steps, the membrane segments were washed 
4 times with TBS and 0.05% Tween 20. After 1 min of incubation 
with LumiGlo Reserve TM chemiluminescence substrate (KPL), the 
chemiluminescence was recorded on X-ray-film within 15 min as 
described above. Developed X-ray films were scanned at 600 dpi on 
an office scanner (Hewlett Packard Scanjet 4890) and stored as 16-
bit grey scale tiff. Grey scales were inverted using ImageJ software 
(http://imagej.nih.gov/ij/), and spots were analysed using the TIGR 
Spotfinder 3.1.1. software (www.tm4.com)  [28] . The signal inten-
sity of spots was calculated by the integration of unsaturated pixels 
in a range between 1 and 65,536 for positive spots. Using the TIGR 
Spotfinder 3.1.1. software, integrated spot intensity was subtracted 
from the background intensity which surrounded the spot (setting: 
circle, diameter 25, top background cut-off 15%). Spot signals were 
considered as positive if the background-subtracted spot intensity 
exceeded 4 times the average intensity of 5 negative spots, which 
consisted of cellulose (without bound peptide).
 Statistical Evaluation of Replicate Analysis of Peptide 
Microarrays 
 Linear regression analysis of correlation plots ( fig. 3 ) including 
calculation of the correlation coefficient between right and left ar-
ray segments was done with Microsoft Excel 2010 for Windows.
 Concordance per run was defined as agreement between both 
array segments, i.e. both indicating positive or both indicating neg-
ative, when moving the cut-off for positivity from low to high sig-
nal intensities. The graphical representation of concordance 
( fig. 4 ) is the percentage of concordant estimated peptides divided 
by all peptides assessed (n = 145) and plotted against signal inten-
sity. The statistical analysis was performed with SAS ® /STAT soft-
ware, version 9.3, SAS System for Windows.
 Results 
 Characteristics of SPOT TM Membranes versus 
In-House Peptide Microarrays 
 Table 3 summarizes various characteristics of synthe-
sized peptides on SPOT TM membranes and microarrays. 
Miniaturization of the SPOT TM membrane method using 
the Celluspot TM array technique resulted in up to 384 pep-
tides in 2 identical segments each on a coated microscope 
slide surface (22 × 60 mm) in comparison to 600 spots on 
the SPOT TM membranes (150 × 100 mm). While the ca-
pacity of presented peptides was comparable between 
 Fig. 3. Distribution of the signal intensities of IgE binding to 145 
overlapping synthetic peptides of peanut allergen Ara h 1 in dupli-
cate peptide segments (left/right) of 5 replicate (B1–B5) microar-
rays according to figure 2. R = Correlation coefficient. 
 Fig. 4. Concordance, defined as the agreement between both array 
segments (left/right) of 5 replicate (B1–B5) Ara h 1 microarray ac-
cording to figure 2 in relation to signal intensity. 
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SPOT TM membranes and microarrays, the array slides 
measured only about one tenth of the size of a comparable 
SPOT TM membrane. With 81 spots/cm 2 , the spot density 
of microarrays is approximately 20 times higher than that 
of the SPOT TM membranes in our synthesis configura-
tion. A complete set of synthetic overlapping peptides 
(n = 372; 15-mer, 4 amino acid offsets) of the 3 subunits 
of the soybean major storage protein β-conglycinin, 
which is composed of 1,517 amino acids, was achieved on 
a single microscope slide ( table 2 ). The peptide synthesis 
on cellulose membranes with the SPOT TM technique al-
lows only 2 membranes to be synthesized in parallel with-
in 1 week. This time-consuming procedure is also neces-
sary for the microarray technique. However, after synthe-
sis of the peptides on a modified cellulose membrane, 50 
identical microarrays can be generated from 1 batch of 
synthesized peptides within 1 week. Taken together, pep-
tide synthesis and spotting of 50 microarrays take 3 weeks 
in comparison to calculated 25 weeks to produce 50 
SPOT TM membranes of 25 individual synthesis batches 
( table 3 ). In principle, this microarray technique would 
allow generating >1,000 slides made from 1 batch of a 
synthesized membrane.
 For an IgE immunodetection of the soybean 
β-conglycinin subunits on separate cut membranes, 4 ml 
incubation solution each was required. Human sera were 
diluted 1: 80 in incubation solution. Accordingly, for the 
detection of all 3 subunits, 150 μl undiluted human sera 
were required. The dilution of human serum for immu-
nodetection of SPOT TM membranes was necessary be-
cause availability of human serum specimen in molecular 
allergology research is usually very much limited. By con-
trast, the peptide microarray covering all 3 soybean pro-
teins required only 45 μl undiluted human serum. Thus, 
using the peptide microarray for IgE epitope mapping, 
70% of the serum required for the detection on the 
SPOT TM membranes was saved. Normalized for the num-
ber of detected peptides, serum savings of 66% were 
achieved by the microarray ( table  3 ). Moreover, if the 
SPOT TM membranes would have also been incubated 
with undiluted human serum according to our detection 
protocol, the use of our microarrays would have been 
99% more efficient with regard to the required amount of 
serum.
 Specificity and Sensitivity of IgE Binding to Synthetic 
Peptides on SPOT TM Cellulose Membrane versus 
Cellulose-Based Microarray Spots 
 Using peptide arrays for the purpose of linear epitope 
analysis of allergenic proteins, the specificity of the IgE 
binding should be verified. Moreover, the higher the sen-
sitivity of the IgE binding to the synthetic peptides, the 
more comprehensive a screening for putative linear IgE-
binding epitopes can be achieved. For a comparative 
analysis of specificity and sensitivity of IgE immunode-
tection on SPOT TM membrane versus microarray, we se-
lected homologous high-molecular weight seed storage 
proteins of peanut and soybean that are considered im-
portant food allergens  [24, 25] . For the verification of 
specificity, a NA serum pool consisting of equal volumes 
of sera from 6 NA human donors was applied. For inves-
tigation of the comparative sensitivity between the 
2 methods, sera from donors with allergy to soybean and 
peanut were applied ( table 1 ). Sera of donors with allergy 
to soybean and peanut as well as the NA serum pool were 
prescreened for the presence or absence of IgE specific to 
soybean, peanut, Ara h 1 and Gly m 5. All 3 peanut and 
soybean allergic individuals had sIgE to soybean and pea-
nut. In addition the 3 sera had sIgE against Gly m 5, as 
was previously determined using an IgE-binding ELISA 
with nGly m 5 coated on the solid phase  [25]  (and unpub-
lished data). Using ImmunoCAP analysis, elevated levels 
of sIgE to nGly m 5 were additionally confirmed for the 
sera No. 28 and 25 in this study. Serum No. 8 is assumed 
to have a level of sIgE against Gly m 5 comparable to that 
of serum No. 28 because of a similar potency of IgE bind-
ing in direct ELISA  [25] . In addition, serum No. 28 had 
high levels of sIgE to Ara h 1. No IgE binding to peanut 
or soybean proteins was found in the serum pool of 6 NA 
donors, using Western blot or ELISA analysis (data not 
shown).
 The specificity was calculated as the ratio between 
true-negative spots and the total number of spots anal-
ysed. Both on SPOT TM cellulose membranes ( fig. 1 a) and 
microarrays ( fig. 2 a), no false-positive detection was ob-
served with any of the 145 Ara h 1-related peptides using 
the NA serum pool. Similarly, the NA serum pool showed 
no binding to any of the Gly m 5 peptides, except for 
1 false-positive binding to peptide 35 of Gly m 5.03, on 
SPOT TM membranes ( fig. 5 a, left). No false-positive detec-
tion was observed with any of the Gly m 5 subunits on the 
microarray ( fig. 5 a, right). In summary, IgE detection of 
both methods of peptide presentation showed a compa-
rable high specificity of 100% ( table 3 ).
 The sensitivity was calculated as the ratio of detected 
spots and the total number of spots analysed. Using se-
rum No. 28, 17 peptides of Ara h 1 bound IgE on a SPOT TM 
membrane ( fig. 1 b). In comparison, 32 peptides of Ara h 1 
located on the microarray bound IgE from serum No. 28 
in both segments of all 5 replicate runs ( fig. 2 b–f). Of the 
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 Fig. 5. Comparison of IgE binding to 372 overlapping synthetic 
peptides of the 3 soybean β-conglycinin subunits Gly m 5.03, 5.01 
and 5.02 on SPOT TM membranes (left) versus microarrays (right; 
display of one segment only).  a Serum pool of 6 NA subjects. 
 b  Serum of soybean allergic subject No. 8.  c Serum of soybean al-
lergic subject No. 25. 
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17 peptides identified on the SPOT TM membrane, 15 were 
detected in both segments of all 5 replicate arrays, and 
another 2 were detected in both segments of each 4/5 ar-
ray. In summary, all IgE-binding peptides on the SPOT TM 
membrane were detected in >97% (83/85) of identical 
peptide duplicates on microarrays. Moreover, 44 peptides 
were considered as IgE binding on microarrays if  ≥ 1/2 
positives in all 5 replicates was taken as a criterion for 
positivity. Consequently, the detection of IgE-binding 
peptides of Ara h 1 with serum No. 28 on microarrays was 
approximately twice as sensitive as on a SPOT TM mem-
brane. Moreover, the sensitivity of IgE binding to syn-
thetic overlapping peptides was investigated for the 3 sub-
units of Gly m 5 using the sera No. 8 and 25 on SPOT TM 
membranes ( fig. 5 b, c, left) and microarrays ( fig. 5 b, c, 
right). On peptide microarrays, only one of the 2 seg-
ments was analysed because of the overall good concor-
dance of detection between the right and the left segment 
as described below. In SPOT TM analysis, IgE binding to 
peptide 35 of Gly m 5.03 is considered non-specific be-
cause of a positive detection in both sera of soy-allergic 
donors as well as in the NA control. By contrast, this pep-
tide did not bind IgE in microarray analysis. The peptides 
93 and 94 of Gly m 5.02 showed intense IgE binding in 
both SPOT TM and microarray analysis. Additional weak 
IgE binding in SPOT TM analysis was not confirmed in mi-
croarray analysis. We assume that the reactivity was 
caused by an unspecific immunodetection on the SPOT TM 
membrane because unspecific IgE binding was only seen 
in the NA controls of the immunodetection of the SPOT TM 
membranes but not of the microarrays. Including those 
presumably false-positive peptides on SPOT TM mem-
branes, 8/372 peptides bound IgE from both sera of soy-
allergic donors on SPOT TM membranes in comparison to 
162/372 peptides on microarrays ( table 3 ). Thus, the de-
tection of IgE binding to Ara h 1- and Gly m 5-related 
peptides was approximately 2–20 times more sensitive on 
our microarrays. A comparable increase in sensitivity was 
observed for the IgE detection of Gly m 5-related peptides 
on our microarrays using serum No. 28, and for the IgE 
detection of Ara h 1-related peptides using the sera No. 8 
and 25 (data not shown).
 Reproducibility and Concordance of IgE Binding to 
Peptides on Microarrays 
 The microarray analysis of IgE binding to synthetic 
overlapping peptides of peanut Ara h 1 was performed on 
5 replicate slides using serum No. 28 ( fig. 2 b–f). Measured 
intensities of IgE binding of the 5 replicates are displayed 
in  figure 3 as a correlation between the right and left seg-
ments. Linear regression of signal intensities of IgE bind-
ing in right versus left segments resulted in a mean slope 
of 0.9958 (range 0.8007–1.1596) and a mean correlation 
coefficient of 0.9370 (range 0.9071–0.9925). With an av-
erage intercept of +928 (range 73–1,462) intensity counts 
of the right segment (y-axis), the IgE detection was slight-
ly more sensitive in the right segment in which the serum 
was applied. Taken together, the signal intensities be-
tween the right and left segments were very much com-
parable.
 Further, the intra-array concordance of both positive 
or both negative results of IgE binding between the 2 seg-
ments was calculated for the 5 replicates. The concor-
dance depending on signal intensity is displayed in  figure 
4 . The average concordance at a signal intensity  ≥ 1 was 
>80% (runs B1 = 91%, B2 = 90%, B3 = 77%, B4 = 97%, 
B5 = 92%).
 Increasing the signal intensity cut-off for positive sig-
nals above 10,000 resulted in >85% concordance for both 
positive or both negative results of IgE binding in all 
5  runs. As examples, positive signals above 10,000 are 
found for the peptides No. 27 (12,009–25,083 signal in-
tensity) or 91 (10,485–25,943 signal intensity) in both 
segments of all 5 replicate slides ( fig. 2 b–f). It should be 
noted that at higher signal intensities for a cut-off be-
tween negative and positive results, the most concordant 
results are concordant negative results. In addition, and 
as described above, 17 peptides which bound IgE in 
SPOT TM analysis bound IgE in >98% (167/170) of identi-
cal peptide replicates on our microarrays and in >97% of 
positive duplicate segments.
 Discussion 
 The mapping of linear IgE-binding epitopes on the ba-
sis of synthetic overlapping peptides, which cover the 
complete primary protein structure, is a common tool to 
investigate B-cell epitopes of allergens. The SPOT TM 
membrane technique, which was introduced by Frank 
and Overwin  [11] , was applied for human IgE epitope 
mapping of various food allergens  [5–7, 12, 29, 30] , in-
cluding peanut Ara h 1  [29] and soybean allergens other 
than Gly m 5  [30, 31] . However, this technique is time 
consuming and requires high amounts of limited avail-
able human sera. Because of these obvious limitations, 
peptide microarrays have recently been developed and 
used for allergen epitope identification, like in other fields 
of nucleic acid  [32] , protein/allergen  [33] and peptide 
 [34] research. Selected examples of published microar-
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rays with synthetic overlapping peptides for human IgE 
epitope mapping of food allergens were on milk lacto-
globulin and casein subunits  [20, 35] , egg ovomucoid 
 [36] , peanut and walnut allergens  [37, 38] , including Ara 
h 1  [37] , shrimp allergens  [39] and Atlantic salmon and 
cod parvalbumins  [40, 41] . Most of the published and 
above-cited microarray-based analysis of linear IgE epit-
opes of food allergens is based on 1 previous microarray 
development for milk allergens  [20] . In comparison to 
other published work, the IgE microarray development 
by Lin et al.  [20] has been the most comprehensively val-
idated in the field of food allergens to our knowledge. 
However, comparability of performance and results to 
the previous SPOT TM membrane technique was limited to 
published data which were obtained by using different 
patients’ sera. In this work, we present the development 
of a novel multipeptide microarray and its validation in 
direct experimental comparison to the SPOT TM mem-
brane technique for linear IgE epitope mapping. The nov-
el microarray is based on the Celluspot TM array technique 
that makes use of peptides covalently synthesized on a 
cellulose porous membrane. Upon dissolution in DMSO, 
the cellulose with covalently bound peptide builds a 3-di-
mensional structure that is spotted and attached onto an 
adhesive foil surface of a standard microscope slide. The 
slides generated by this procedure were stable for 1 year 
at 4   °   C under dry storage conditions (data not shown). 
Each slide had a capacity to present 384 peptides in du-
plicate segments, which was appropriate to present over-
lapping peptides (15-mer, 4 amino acid offsets) of the 
high-molecular weight soybean allergen Gly m 5 that is 
composed of three 50–71 kDa subunits  [42] . We investi-
gated the IgE binding of 3 individual sera, donated from 
soybean- and peanut-allergic individuals, to 4 individual 
vicilin-like proteins, namely peanut Ara h 1 and the 
3  soybean Gly m 5 subunits. In our study, we observed a 
very high specificity of IgE detection to synthetic peptides 
using both SPOT TM membranes and microarray slides. 
We achieved an increase in sensitivity between 2- and 20-
fold using the microarray, while the required amount of 
human sera was reduced by at least two thirds over the 
SPOT TM membrane technique ( table 3 ). With a total vol-
ume of 50 μl of serum to study in detail, the IgE binding 
to a high-molecular weight allergen such as Gly m 5 makes 
the cellulose-based peptide microarray an ideal tool for 
studying populations on the individual subject level with 
limited availability of serum specimen, such as paediatric 
study groups. Having in mind the focus of a primary 
screening for potential linear IgE epitopes of allergens 
that would require further verification on the level of a 
full-length protein, our novel peptide microarray 
 presented appropriate and acceptable reproducibility 
above an average concordance of >80% between dupli-
cate intra-array detection and for multiple interarray de-
tection of the most prominent IgE-binding peptides. 
Based on the theoretical synthesis of 50 identical peptide 
batches using the SPOT TM membrane technique, the gen-
eration of 50 identical microarrays from 1 peptide synthe-
sis batch was calculated to be 8 times faster ( table 3 ). Fur-
ther, considering the possibility to potentially generate 
>1,000 slides from 1 peptide synthesis batch, this micro-
array technique is appropriate to investigate large study 
groups on the individual level. In summary, we found the 
cellulose-based microarray superior to the SPOT TM mem-
brane technique in many ways. The performance of the 
peptide microarrays appeared to be similar to that of the 
previously published peptide microarray for milk aller-
gens  [20] . While we applied 50 μl of undiluted serum to 
1 array, Lin et al.  [20] used 250 μl of 1: 5 diluted serum. 
The purity of synthesized peptides was estimated between 
70 and 80% for both microarrays, and IgE bound to pep-
tides was detected using a polyclonal antibody directed 
against human IgE. Lin et al.  [20] reported a specificity of 
>96% with regard to less than 10/289 peptides that showed 
non-specific binding. Using our microarray, we did not 
observe non-specific binding to any of the 145 and 372 
presented peptides, respectively. Differences between 
both microarray systems are identified in the synthesis of 
peptides, preparation of peptide microarrays and record-
ing of signals of IgE binding to peptides. We were able to 
perform in-house multiple peptide synthesis in compari-
son to the use of commercially synthesized peptides by 
Lin et al.  [20] . In our hands, this turned out to be a very 
flexible and cost-effective option. Our in-house synthe-
sized peptides were covalently linked to a 3-dimensional 
cellulose polymer structure which allows a high-density 
presentation of peptides in comparison to monolayer 
printing on modified glass slides (Intavis personal com-
munication). Considering the low concentration of sIgE 
at the ng/ml level in comparison to potentially competi-
tive sIgG at the μg/ml level, a polymeric high-density pre-
sentation of peptides, at least in theory, may be advanta-
geous over a monolayer peptide presentation. The pub-
lished microarray further required an array reader for 
signal recording, while our method of detection required 
low-tech chemiluminescence exposure on X-ray film and 
digitalization on a standard desktop scanner. Indepen-
dently, the recorded microarray signals were accessible 
for open access array software for spot identification and 
analysis.
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 Conclusion 
 With special regard to using our method as a research 
tool, we have developed and established a novel, simple, 
cost-effective, sensitive and specific peptide microarray for 
the investigation of potential IgE epitopes of peanut and 
soybean allergens in large study groups, including paediat-
ric individuals of whom the amount of available serum do-
nations is usually very much limited. Likewise, the method 
may be applied to discover peptides that bind IgG from 
human serum. The identification of sIgE and IgG-binding 
patterns can contribute to the development of novel diag-
nostic and therapeutic approaches in food allergy and pro-
vides basic information on epitopes with regard to the al-
lergen risk assessment of novel proteins or foods derived 
from novel natural food sources or biotechnology.
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